DSM announces settlement of Federal Class Antitrust Litigation

HEERLEN, NETHERLANDS, Jun 15 (MARKET WIRE) —
A class of businesses that purchased ethylene proplylene diene monomer
(“EPDM”) between 1997 and 2001 has reached agreement with two
subsidiaries of Royal DSM N.V., the Life Sciences and Materials Sciences
company, to settle a long- running antitrust dispute before trial in
return for a payment of $25 million (USD).

The EPDM class action, pending in the United States District Court for the
District of Connecticut, was vigorously litigated by both sides; the DSM
defendants consistently denied any wrongdoing in connection with the
allegations. In 2006, competition enforcement authorities in the European
Union, the United States and Canada concluded their EPDM investigations
without bringing any charges against DSM or any of its employees. The DSM
Defendants have now entered into the settlement to eliminate the burden,
expense and risk of further litigation. The proposed class action
settlement is subject to Court approval. If approved, and following due
notice to the class members, the class action will be dismissed with
prejudice and all claims asserted in the class action against the DSM
Defendants will be released.

DSM – the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve
performance. Its end markets include human and animal nutrition and
health, personal care, pharmaceuticals, automotive, coatings and paint,
electrical and electronics, life protection and housing. DSM manages its
business with a focus on the triple bottom line of economic performance,
environmental quality and social responsibility, which it pursues
simultaneously and in parallel. DSM has annual net sales of about EUR 8
billion and employs some 22,700 people worldwide. The company is
headquartered in the Netherlands, with locations on five continents. DSM
is listed on Euronext Amsterdam. More information:
www.dsm.com

For more information:

DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 10 4590275
e-mail media.relations@dsm.com e-mailinvestor.relations@dsm.com

[HUG#1423757]

Press release-pdf:

http://hugin.info/130663/R/1423757/372539.pdf

Copyright 2010, Market Wire, All rights reserved.

DSM N.V. : DSM announces settlement of Federal Class Antitrust Litigation

A class of businesses that purchased ethylene proplylene diene monomer(“EPDM”) between
1997 and 2001 has reached agreement with two subsidiaries of Royal DSM N.V., the Life
Sciences and Materials Sciences company, to settle a long-running antitrust dispute
before trial in return for a payment of $25 million (USD).

The EPDM class action, pending in the United States District Court for the District of
Connecticut, was vigorously litigated by both sides; the DSM defendants consistently
denied any wrongdoing in connection with the allegations. In 2006, competition
enforcement authorities in the European Union, the United States and Canada concluded
their EPDM investigations without bringing any charges against DSM or any of its
employees. The DSM Defendants have now entered into the settlement to eliminate the
burden, expense and risk of further litigation. The proposed class action settlement is
subject to Court approval. If approved, and following due notice to the class members,
the class action will be dismissed with prejudice and all claims asserted in the class
action against the DSM Defendants will be released.

DSM – the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end
markets include human and animal nutrition and health, personal care, pharmaceuticals,
automotive, coatings and paint, electrical and electronics, life protection and housing.
DSM manages its business with a focus on the triple bottom line of economic performance,
environmental quality and social responsibility, which it pursues simultaneously and in
parallel. DSM has annual net sales of about € 8 billion and employs some 22,700 people
worldwide. The company is headquartered in the Netherlands, with locations on five
continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com

http://www.dsm.com/

For more information:

DSM Corporate Communications Herman Betten DSM Investor Relations Hans Vossen

tel. +31 (0) 45 5782017
tel. +31 (0) 45 5782864

fax +31 (0) 45 5740680
fax +31 (0) 10 4590275

e-mail media.relations@dsm.com mailto:media.relations@dsm.com e-mail investor.relations@dsm.com mailto:investor.relations@dsm.com

DSM Investor Relations

Hans Vossen

tel. +31 (0) 45 5782864

fax +31 (0) 10 4590275
e-mail investor.relations@dsm.com mailto:investor.relations@dsm.com

HUG#1423757

Scientist calls for more research into vitamin D’s link with Alzheimer’s, vascular dementia

Washington, May 27 (ANI): Based on an analyses of previous studies, a research article suggests that further investigation into Vitamin D deficiency’s possible direct or indirect linkages with Alzheimer’s disease and vascular dementia is needed.

William B. Grant, PhD of the Sunlight, Nutrition, and Health Research Center (SUNARC), writes that low serum levels of 25-hydroxyvitamin D [25(OH)D] have been associated with increased risk for cardiovascular diseases, diabetes mellitus, depression, dental caries, osteoporosis, and periodontal disease, all of which are either considered risk factors for dementia or have preceded incidence of dementia.

The author points out that a number of studies reported in 2008 that those with higher serum 25(OH)D levels had greatly reduced risk of incidence or death from cardiovascular diseases.

He further writes that several studies have correlated tooth loss with development of cognitive impairment and Alzheimer’s disease or vascular dementia.

There are two primary ways that people lose teeth: dental caries and periodontal disease. Both conditions are linked to low vitamin D levels, with induction of human cathelicidin by 1,25-dihydroxyvitamin D being the mechanism.

Grant also underscores that fact that there is refers laboratory evidence for the role of vitamin D in neuroprotection and reducing inflammation, and ample biological evidence to suggest an important role for vitamin D in brain development and function.

He says that these supportive lines of evidence suggest that studies of incidence of dementia with respect to prediagnostic serum 25(OH)D or vitamin D supplementation are warranted.

The researcher adds that given that the elderly are generally vitamin D deficient, and since vitamin D has so many health benefits, those over the age of 60 years should consider having their serum 25(OH)D tested, looking for a level of at least 30 ng/mL but preferably over 40 ng/mL, and supplementing with 1000-2000 IU/day of vitamin D3 or increased time in the sun spring, summer, and fall if below those values.

Writing in the article, Dr. Grant states, “There are established criteria for causality in a biological system. The important criteria include strength of association, consistency of findings, determination of the dose-response relation, an understanding of the mechanisms, and experimental verification.

To date, the evidence includes observational studies supporting a beneficial role of vitamin D in reducing the risk of diseases linked to dementia such as vascular and metabolic diseases, as well as an understanding of the role of vitamin D in reducing the risk of several mechanisms that lead to dementia.”

The article has been published in the Journal of Alzheimer’s Disease. (ANI)

Michelle Obama and mum to feature in Mother’s Day issue of Essence

Washington, April 6 (ANI): U.S. First Lady Michelle Obama’s mother, Marian Robinson, will feature with her in the May issue of Essence magazine.

Marian joined her daughter for a joint interview and cover shoot for the U.S. Mother’s Day issue of the magazine.

The interview was conducted in Michelle’s East Wing Office at about a month after the inauguration.

The mother-daughter duo discussed family, life in the White House, and the importance of good role models.

Marian, 71, said her role model was her daughter.

“Michelle has always been Michelle. And she has always accomplished whatever it was she set out to accomplish,” Politico.com quoted Robinson as saying in the interview, which is not yet posted online.

“I have always looked up to Michelle because she has been able to do things that I couldn’t do emotionally, psychologically or physically. I think she is amazing,” she said.

Michelle was also all praise for her mother.

“She made me who I am,” said the First Lady.

She also discussed her growing platform, giving it a global spin.

“We have to talk about flex hours and exercise and nutrition and health and what that means. And we have to talk about values, and our relationship with men. All of those are part of the conversation that I think we need to have, not just in this country, but around the world,” she said.

The mother-daughter team also discussed parenting.

When Marian was asked whether she planned to write a parenting book, her daughter jumped in with a laugh, and she said: “We are working on it.” (ANI)

Meghalaya Rural Development Society changing life in villages

Shillong, Feb.18 (ANI): The Meghalaya Rural Development Society (MRDS) programme is making a major difference to the lives of poor and backward people in villages here.

Jointly funded by government and the International Fund for Agriculture Development (IFAD), the Meghalaya Rural Development Society (MRDS) aims to help villagers in a sustainable manner through promotion of improved livelihood opportunities and strengthening local institutions that relate to livelihood development.

The MRDS has been able to benefit several unemployed villagers in the South Garo Hills in Meghalaya, in the remotest and most backward district of the state.

“The farmers benefit in capacity building after we give them training and provide relevant information. We expose them to different technologies and enable them to choose which technology suits them better and they are confident enough to undertake,” said Panseng R. Marak, Project Manager, Meghalaya Rural Development Society (MRDS), South Garo Hills.

“I use to go to the village to give training in areas like family planning, nutrition and health sanitation especially for the gender. That’s the training I give to the people. It’s like an awareness,” said Lily Sangma, MRDS official, South Garo Hills.

The Meghalaya Rural Development Society holds meetings and awareness programmes to educate and help people in economic development, education, health, cultivation, savings, forming of women groups.

It helps them, directly or indirectly, and enhances villagers’ capabilities while encouraging them as well to benefit from banking activities such as saving and borrowing.

“The project has helped us, we bring fish from the market and cultivate in the fishery, after that we sell it and distribute the money among the members of our group,” said Mitha M. Sangma, a local resident in South Garo Hills.

“We took loans through MRDS. We are working in poultry and pig farms and we have also taken part in a training programme in Shillong,” said Forman Sangma, a local resident.

The whole project covers 14 selected Blocks in five districts of the state-East Khasi Hills, Jaintia Hills, East Garo Hills, South Garo Hills, and Ri-Bhoi district.

The programme has come as a boon to the villagers and has given the area an economic facelift and much-needed development. By Peter Alex Todd(ANI)

How gut bacteria prevents cancer, inflammatory bowel disease in humans

Washington, Feb 6 (ANI): In a new study, researchers have found that bacteria present in the gut can release substances that may protect the body against colon cancer and inflammatory bowel disease.

Scientists at the University of Aberdeen Rowett Institute of Nutrition and Health and from the MTT Agrifood Research Institute in Finland showed that bacteria in the human gut convert linoleic acid, a naturally-occurring fat in the diet, into a form called conjugated linoleic acid (CLA) which is absorbed by the gut wall.

Dr John Wallace of the Rowett Research Institute said that there exist different types of CLA, out of which only a few have beneficial effects, and that “good” form of CLA is present in dairy foods such as milk and cheese.”

“But eating lots of dairy foods won’t necessarily help our gut health as most of the fats are digested in the small intestine before they get to the large intestine, where most of our gut bacteria are found,” he said.

The findings indicated that gut bacteria produce several different forms of CLA, most of which are of the “good” kind.

Bit Wallace stressed that more extensive studies are needed, as one subject produced small amounts of a CLA whose effects are much less clear.

Thus, the researchers deduced that if small quantities of dietary linoleic acid could be delivered to the large intestine, the effects on gut health would be generally beneficial in most people.

“The results are of special interest for individuals using anti-obesity treatments that prevent the small intestine from absorbing fats. This means that those fats – including linoleic acid – will pass into the large intestine and the gut bacteria will produce CLA. It has to be the correct CLA, so it is important to understand how individuals produce different CLA. This must depend on which types of bacteria are present,” said Wallace.

The study has been published in the journal Microbiology. (ANI)